Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001545009 | SCV000954040 | uncertain significance | not provided | 2024-09-14 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 190 of the SCN5A protein (p.Arg190Trp). This variant is present in population databases (rs199473068, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SCN5A-related conditions. ClinVar contains an entry for this variant (Variation ID: 657115). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Color Diagnostics, |
RCV001841992 | SCV001359261 | uncertain significance | Cardiac arrhythmia | 2022-11-16 | criteria provided, single submitter | clinical testing | This missense variant replaces arginine with tryptophan at codon 190 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 4/242820 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Centre for Mendelian Genomics, |
RCV001196953 | SCV001367587 | uncertain significance | Sick sinus syndrome 1 | 2020-03-05 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3. |
Center For Human Genetics And Laboratory Diagnostics, |
RCV001258364 | SCV001435333 | uncertain significance | Brugada syndrome 1 | 2020-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001545009 | SCV001764248 | uncertain significance | not provided | 2025-02-10 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ai |
RCV001545009 | SCV002502933 | uncertain significance | not provided | 2021-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345853 | SCV002653323 | uncertain significance | Cardiovascular phenotype | 2020-12-04 | criteria provided, single submitter | clinical testing | The p.R190W variant (also known as c.568C>T), located in coding exon 4 of the SCN5A gene, results from a C to T substitution at nucleotide position 568. The arginine at codon 190 is replaced by tryptophan, an amino acid with dissimilar properties, and is located in the DI-S2/S3 region of the protein.. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV001841992 | SCV004827330 | uncertain significance | Cardiac arrhythmia | 2023-11-30 | criteria provided, single submitter | clinical testing |